The relatively higher HLA-DQA1/DRB1 positivity in controls (IBD without AZA-ADRs) versus kidney donors may partly explain why only IBD patients are vulnerable to AZA-AP [16]. Here, HLA-DRB1 is linked to inflammatory bowel disease.